Clinical Trial

A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
the goal of this study is to compare the efficacy of ustekinumab with infliximab for the treatment of ulcerative colitis aim of the study : 1. Compare effectiveness of ustekinumab versus infliximab therapy in remission achievement in UC patients. 2. Compare safety of ustekinumab therapy versus infliximab therapy in UC 3. To asses quality of life of ustekinumab therapy versus infliximab therapy in UC patients.
Trial Details
NCT Number NCT06786507
Lead Sponsor Helwan University
Conditions Ulcerative Colitis (UC)
Enrollment 100 participants
Start Date 2025-05-15
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-22